Wegovy vs Mounjaro Safety: Clinical Evidence & Pricing Compared
Is Wegovy Safer Than Mounjaro? Understanding the Key Differences
When evaluating whether Wegovy is safer than Mounjaro, it's essential to understand their distinct mechanisms and clinical profiles. Wegovy contains semaglutide, a GLP-1 receptor agonist that has been extensively studied through the STEP trial programme, whilst Mounjaro contains tirzepatide, a newer dual GIP/GLP-1 receptor agonist studied in the SURMOUNT trials. Both medications have undergone rigorous safety evaluation by the MHRA, though they each carry specific contraindications and precautions. The safety profile depends largely on individual medical history, existing conditions, and how each person responds to the different receptor mechanisms.
Neither medication can be declared universally "safer" than the other, as safety is highly individualised based on patient factors such as diabetic status, cardiovascular history, gastrointestinal sensitivity, and concurrent medications. Both Wegovy and Mounjaro are available from EverydayMeds following clinical assessment, where qualified prescribers can evaluate which option may be more suitable for your specific circumstances. The question of whether Wegovy is safer than Mounjaro for you personally requires professional medical evaluation rather than a general comparison.
Wegovy vs Mounjaro Pricing: FIRST40 and DOSE25 Discount Codes
Understanding the cost implications when deciding between these medications is crucial for long-term treatment planning. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). New customers apply discount code FIRST40 at checkout to access these prices, whilst returning customers use code DOSE25. Bundle options provide convenience for multi-month supply, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, ensuring continuity without multiple orders.
The pricing structure reflects the mandatory dose escalation protocol required for both medications, though Mounjaro follows a different titration schedule. When considering whether Wegovy is safer than Mounjaro from a cost-benefit perspective, the pricing allows you to start with lower doses whilst monitoring tolerability and effectiveness. Both medications require the same clinical assessment process and next-day cold-chain delivery, ensuring you receive genuine, properly stored medication regardless of which option your prescriber recommends.
Clinical Safety Evidence: STEP Trials and Real-World Data
The STEP clinical trial programme provides comprehensive safety data for Wegovy, with STEP 1 demonstrating the safety profile over 68 weeks in adults with obesity. As reported by Wilding et al., NEJM, 2021, the most common adverse events were gastrointestinal, typically mild to moderate and decreasing over time. The trials showed that serious adverse events were similar between Wegovy and placebo groups, though individual tolerability varies significantly.
When comparing whether Wegovy is safer than Mounjaro, both medications share similar gastrointestinal side effect profiles due to their GLP-1 activity, though the dual receptor action of Mounjaro may present different tolerability patterns. The MHRA has approved both medications with comprehensive prescribing information, and both carry additional monitoring status. Your prescriber will evaluate your specific risk factors when determining which medication may be more appropriate for your circumstances.
How Wegovy Works: GLP-1 Mechanism and Safety Implications
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural hormone GLP-1 to reduce appetite and promote satiety after smaller meals. This mechanism works primarily in the brain's appetite centres and the digestive system to slow gastric emptying, which contributes to feeling fuller for longer periods. The once-weekly injection via FlexTouch pen provides consistent medication levels, reducing the daily medication burden compared to oral alternatives. Understanding this mechanism helps explain why certain side effects occur, particularly the gastrointestinal effects related to slowed digestion. The GLP-1-only approach of Wegovy has been extensively studied, providing a well-established safety database for prescribers to reference when considering individual patient suitability.
EverydayMeds Ordering Process: Clinical Assessment to Delivery
Starting your Wegovy treatment through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Qualified prescribers review your assessment within standard 3 working days, or 24 hours with express review, ensuring thorough evaluation of whether Wegovy is appropriate for your circumstances. Upon approval, your medication is dispatched via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C temperature throughout transit. The process includes clear instructions for storage, administration, and what to expect during dose escalation. Our GPhC-registered pharmacy (#9012878) ensures all medications are genuine, properly stored, and dispensed according to UK regulations, with ongoing support available throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Stability
Wegovy offers a practical advantage in storage flexibility compared to Mounjaro, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This enhanced temperature tolerance makes Wegovy more suitable for travel or situations where consistent refrigeration may be challenging. The FlexTouch pen design provides reliable dose delivery with clear dose windows and simple injection technique, reducing administration errors. Storage requirements include keeping unused pens refrigerated at 2-8°C and protecting from light, though the extended room temperature stability provides peace of mind for daily use. When considering whether Wegovy is safer than Mounjaro, the storage stability can contribute to medication adherence and proper dosing, as improperly stored medication may lose effectiveness or pose safety concerns.
Wegovy Safety Profile: Individual Risk Assessment Considerations
Determining whether Wegovy is safer than Mounjaro requires individualised assessment of your specific health profile, including cardiovascular history, diabetic status, and gastrointestinal sensitivity. Wegovy's established safety database from the STEP trials provides comprehensive information about potential adverse events, contraindications, and drug interactions that your prescriber will evaluate. The medication carries specific warnings for patients with certain conditions, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
The safety comparison between these medications isn't straightforward, as both target overlapping pathways but through different mechanisms that may suit different patients. Your prescriber will consider factors such as your response to previous GLP-1 medications, concurrent treatments, and individual risk factors when determining which option may be more appropriate. The question of whether Wegovy is safer than Mounjaro ultimately depends on your personal medical circumstances rather than general population data.
Start Your Assessment: FIRST40 and DOSE25 Discount Codes Available
Ready to explore whether Wegovy is right for you through professional clinical assessment? New customers can apply discount code FIRST40 at checkout to access our competitive pricing, whilst returning customers use code DOSE25 for continued savings. The 0.25mg starter dose at £79.99 allows you to begin treatment whilst monitoring tolerability and effectiveness under prescriber guidance. Our clinical team can discuss both Wegovy and Mounjaro options during your assessment, helping determine which medication aligns with your medical history and treatment goals. Visit https://everydaymeds.co.uk/collections/wegovy to begin your confidential assessment, with qualified prescribers available to guide your treatment decision. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you receive expert guidance regardless of which option proves most suitable for your circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
